Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression

被引：41

作者：

Shin, DM

Mao, L

Papadimitrakopoulou, VM

Clayman, G

El-Naggar, A

Shin, HJC

Lee, JJ

Lee, JS

Gillenwater, A

Myers, J

Lippman, SM

Hittelman, WN

Hong, WK

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA

[2] Univ Texas, MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA

[3] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA

[4] Univ Texas, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

[5] Univ Texas, MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA

[6] Univ Texas, MD Anderson Canc Ctr, Dept Clin Invest, Houston, TX 77030 USA

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2000年 / 92卷 / 01期

关键词：

D O I：

10.1093/jnci/92.1.69

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：69 / 73

页数：5

共 36 条

[1]

BOYLE JO, 1993, CANCER RES, V53, P4477

[2]

DeLaney TF, 1996, CANCER RES, V56, P2277

[3] CLINICAL IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE [J].

HARRIS, CC ;

HOLLSTEIN, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (18) :1318-1327

[4] 13-CIS-RETINOIC ACID IN THE TREATMENT OF ORAL LEUKOPLAKIA [J].

HONG, WK ;

ENDICOTT, J ;

ITRI, LM ;

DOOS, W ;

BATSAKIS, JG ;

BELL, R ;

FOFONOFF, S ;

BYERS, R ;

ATKINSON, EN ;

VAUGHAN, C ;

TOTH, BB ;

KRAMER, A ;

DIMERY, IW ;

SKIPPER, P ;

STRONG, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (24) :1501-1505

[5] PREVENTION OF 2ND PRIMARY TUMORS WITH ISOTRETINOIN IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].

HONG, WK ;

LIPPMAN, SM ;

ITRI, LM ;

KARP, DD ;

LEE, JS ;

BYERS, RM ;

SCHANTZ, SP ;

KRAMER, AM ;

LOTAN, R ;

PETERS, LJ ;

DIMERY, IW ;

BROWN, BW ;

GOEPFERT, H .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (12) :795-801

[6] Recent advances in chemoprevention of cancer [J].

Hong, WK ;

Sporn, MB .

SCIENCE, 1997, 278 (5340) :1073-1077

[7] A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY UTILIZING P53 AND GADD45 IS DEFECTIVE IN ATAXIA-TELANGIECTASIA [J].

KASTAN, MB ;

ZHAN, QM ;

ELDEIRY, WS ;

CARRIER, F ;

JACKS, T ;

WALSH, WV ;

PLUNKETT, BS ;

VOGELSTEIN, B ;

FORNACE, AJ .

CELL, 1992, 71 (04) :587-597

[8]

KILLA V, 1997, J BIOL CHEM, V272, P9742

[9]

Kim SK, 1996, CANCER RES, V56, P2519

[10]

KIM SY, 1994, P AM ASSOC CANC RES, V35, pA3716

← 1 2 3 4 →